Axsome Therapeutics, Inc. (AXSM)
216.58
-4.17
(-1.89%)
USD |
NASDAQ |
Sep 14, 16:00
216.53
-0.05
(-0.02%)
After-Hours: 20:00
Axsome Therapeutics Market Cap : 11.33B for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 14, 2026 | 11.33B |
| September 11, 2026 | 11.55B |
| September 10, 2026 | 11.04B |
| September 09, 2026 | 11.02B |
| September 08, 2026 | 10.87B |
| September 04, 2026 | 10.81B |
| September 03, 2026 | 10.90B |
| September 02, 2026 | 10.98B |
| September 01, 2026 | 10.61B |
| August 31, 2026 | 10.38B |
| August 28, 2026 | 10.41B |
| August 27, 2026 | 10.79B |
| August 26, 2026 | 10.83B |
| August 25, 2026 | 10.75B |
| August 24, 2026 | 10.74B |
| August 21, 2026 | 10.87B |
| August 20, 2026 | 10.88B |
| August 19, 2026 | 11.41B |
| August 18, 2026 | 11.28B |
| August 17, 2026 | 11.31B |
| August 14, 2026 | 11.17B |
| August 13, 2026 | 11.18B |
| August 12, 2026 | 11.23B |
| August 11, 2026 | 11.28B |
| August 10, 2026 | 11.55B |
| Date | Value |
|---|---|
| August 07, 2026 | 11.13B |
| August 06, 2026 | 10.99B |
| August 05, 2026 | 11.13B |
| August 04, 2026 | 10.91B |
| August 03, 2026 | 10.85B |
| July 31, 2026 | 11.21B |
| July 30, 2026 | 12.07B |
| July 29, 2026 | 11.69B |
| July 28, 2026 | 12.04B |
| July 27, 2026 | 12.26B |
| July 24, 2026 | 12.39B |
| July 23, 2026 | 12.42B |
| July 22, 2026 | 12.32B |
| July 21, 2026 | 12.18B |
| July 20, 2026 | 11.40B |
| July 17, 2026 | 11.83B |
| July 16, 2026 | 12.19B |
| July 15, 2026 | 12.21B |
| July 14, 2026 | 12.10B |
| July 13, 2026 | 11.74B |
| July 10, 2026 | 12.02B |
| July 09, 2026 | 12.80B |
| July 08, 2026 | 12.63B |
| July 07, 2026 | 12.84B |
| July 06, 2026 | 12.47B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.072T |
| Liquidia Corp. | 5.819B |
| Filana Therapeutics, Inc. | 34.72M |
| CorMedix, Inc. | 612.79M |
| Eloxx Pharmaceuticals, Inc. | 65.79M |
Market Cap Related Metrics
| PS Ratio | 14.20 |
| Price to Book Value | 135.97 |
| Price | 216.58 |
| Earnings Yield | -1.74% |